| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |